The study on the efficacy of improving cancer-related fatigue after the treatment with ginseng Guben Oral liquid
Journal of Ginseng Research · 2025-08 · 100894
DOI: 10.1016/j.jgr.2025.08.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ginseng Research, 2025-08. Verfasst von Linlin Wang und 29 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shandong First Medical University.
Abstract (Originalsprache)
Background
Cancer-related fatigue (C-RF) is a prevalent and debilitating symptom among cancer patients, significantly impacting their quality of life. This study aimed to evaluate the efficacy and safety of Ginseng Guben Oral Liquid in treating C-RF.
Methods
In this multicentric, randomized controlled, prospective study we recruited 240 patients with advanced solid tumors who were hospitalized at different hospitals from April 2021 to May 2022. 240 patients were enrolled and randomly assigned to an experimental group or a control group with 120 patients in each group. The primary endpoint was the change in the Brief Fatigue Inventory (BFI) score from baseline after 6 weeks of treatment. Secondary endpoints included changes in Hospital Anxiety and Depression Scale-Anxiety/Depression (HADS-A/D), Eastern Cooperative Oncology Group (ECOG), Cancer Fatigue Scale (CFS), and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTCQLQ-C30) after 6 weeks of treatment.
Results
The experimental group showed statistically significant improvements ( p < 0.05) in fatigue, anxiety, depression, and quality of life compared to the control group after 6 weeks of treatment. Based on the Full Analysis Set (FAS), statistically significant improvements were observed across primary endpoints of BFI (mean difference (MD) = −1.28, 95 % confidence interval (CI): −1.41 to −0.53). No significant difference in adverse events was observed between the two groups (95 % CI: −0.7 % to 4.0 %).
Conclusion
Ginseng Guben Oral Liquid effectively alleviated the symptoms of C-RF in cancer patients. These findings support the integration of traditional Chinese medicine with contemporary cancer therapies.
Förderung
- Shandong First Medical University
Zitieren
APA
Wang, L., Li, Z., Wang, P., Zhu, J., Man, L., Cheng, Y., Lv, J., Yang, C., Xu, J., Zhao, G., Shen, W., Bai, Y., Kang, Z., Chen, R., Zhou, L., Wang, M., Yao, L., Xing, Z., He, W., …, & Yu, J. (2025). The study on the efficacy of improving cancer-related fatigue after the treatment with ginseng Guben Oral liquid. Journal of Ginseng Research, 100894. https://doi.org/10.1016/j.jgr.2025.08.005
Vancouver
Wang L, Li Z, Wang P, Zhu J, Man L, Cheng Y, et al. The study on the efficacy of improving cancer-related fatigue after the treatment with ginseng Guben Oral liquid. Journal of Ginseng Research. 2025:100894. doi:10.1016/j.jgr.2025.08.005
BibTeX
@article{Wang2025,
author = {Wang, Linlin and Li, Zhanlin and Wang, Peng and Zhu, Jie and Man, Li and Cheng, Yufeng and Lv, Jie and Yang, Changqing and Xu, Juan and Zhao, Guangli and Shen, Wei and Bai, Yuansong and Kang, Zhao and Chen, Ruirui and Zhou, Lei and Wang, Mingyun and Yao, Lige and Xing, Zhihong and He, Wei and Wang, Xin and Chen, Weiyong and Li, Chenghui and Zhu, Chaoyong and Zhang, Yongjun and Yang, Chengliang and Yuan, Zhiping and Li, Zuoyan and Jin, Meisi and Liu, Bin and Yu, Jinming},
title = {The study on the efficacy of improving cancer-related fatigue after the treatment with ginseng Guben Oral liquid},
journal = {Journal of Ginseng Research},
year = {2025},
pages = {100894},
doi = {10.1016/j.jgr.2025.08.005}
}
EUVIMED